By
Jeff Dale2023-10-10T16:45:00
A U.S. affiliate of British bank HSBC agreed to pay $2 million as part of a settlement with the Financial Industry Regulatory Authority (FINRA) addressing alleged inaccurate disclosures related to conflicts of interest.
HSBC Securities (USA) agreed to be censured and certify its compliance in reaching settlement, according to a FINRA disciplinary action published Monday.
Between January 2013 and December 2021, HSBC published research reports containing approximately 275,000 disclosure inaccuracies about its conflicts of interest, FINRA alleged.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2024-01-31T21:15:00Z By Jeff Dale
The Bank of England’s Prudential Regulation Authority penalized two HSBC units £57.4 million (U.S. $73 million) over historic failures in deposit protection identification and notification.
2023-12-27T18:24:00Z By Kyle Brasseur
Electronic trading platform Interactive Brokers received a $3.5 million penalty from the Financial Industry Regulatory Authority for multiple alleged violations of the self-regulatory organization’s rules regarding execution and supervision.
2023-12-06T19:16:00Z By Kyle Brasseur
The Financial Industry Regulatory Authority published disciplinary actions against four firms for failing to establish, maintain, and enforce a reasonably designed supervisory system over fully paid securities lending.
2026-02-05T00:55:00Z By Ruth Prickett
Major accountancy firms in France are under investigation for anti-competitive practices. The French competition watchdog embarked on a series of “unannounced inspections” and removed documents relating to audit and reporting on Jan. 13.
2026-02-03T23:22:00Z By Neil Hodge
The European Commission has launched a formal investigation against Elon Musk’s X under the Digital Services Act over fears that its AI tool Grok may be producing and disseminating illegal material.
2026-02-03T22:57:00Z By Adrianne Appel
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.
Site powered by Webvision Cloud